Logo

BioMérieux

In Brief This Week: MLA Diagnostics, BC Platforms, Oncocyte, Biological Dynamics, Devyser, More

News items for the week of Dec. 4, 2023

BioMérieux Q3 Revenues Dip Slightly

The firm confirmed its full-year guidance for organic sales growth of between 4 percent and 6 percent.

Oxford Nanopore Technologies Outlines Plans to Expand Presence in Clinical, Applied Markets
Premium

The firm said it is actively forging partnerships in the clinical and applied industrial markets to drive adoption of its nanopore sequencing products.

Oxford Nanopore Nabs £70M Investment From BioMérieux, Signs Clinical Collaboration With Mayo Clinic

The investment comes after Oxford Nanopore and BioMérieux's collaboration agreement earlier this year for the development of infectious disease diagnostics.

BioMérieux's BioFire Defense Secures $18.8M US DoD Contract for Infectious Disease Testing

The order-dependent contract is for maintenance and support of a version of the BioFire FilmArray 2.0 molecular diagnostic instrument through January 2029.

Sep 22, 2023

BioMérieux Submits Dual FDA Marketing, CLIA Waiver Application for Respiratory, Sore Throat Panel

Sep 1, 2023

BioMérieux Q2 Revenues Rise 5 Percent

Jun 30, 2023

People in the News at BioMérieux, City of Hope, Ultima Genomics, NeoGenomics, Burning Rock, More

Jun 16, 2023

People in the News at Foundation Medicine, Personalis, Agendia, BioMérieux, Genetic Signatures

May 9, 2023

BioMérieux Gets CLIA Waiver for BioFire SpotFire Respiratory Panel Mini

Apr 27, 2023

BioMérieux Q1 Revenues Rise 8 Percent

Apr 21, 2023

BioMérieux, Oxford Nanopore to Break New Ground With Infectious Disease Diagnostics Pact
Premium

Apr 18, 2023

Multicenter Study Finds BioFire Joint Infection Panel Shows High Accuracy Despite Limitations
Premium

Apr 17, 2023

Oxford Nanopore Technologies, BioMérieux to Develop Infectious Disease Diagnostics

Apr 6, 2023

New Products Posted to GenomeWeb: Pacific Biosciences, Vizgen, Metabolon, Shimadzu, BioMérieux

Mar 30, 2023

Rapid Pathogen ID/AST Market Begins to Recover Post-COVID as Drug-Resistant Infections Spike
Premium

Mar 10, 2023

BioMérieux, Biocartis, Beckman Coulter Gain FDA 510(k) Clearances in February

Mar 9, 2023

BioMérieux Sees New Clinical Diagnostic Product Launches Fueling Future Revenue Growth
Premium

Feb 16, 2023

BioMérieux SpotFire MDx System Leverages Novel Approaches for POC Market
Premium

Feb 8, 2023

BioMérieux Point-of-Care System, Respiratory Panel Get FDA 510(k) Clearance, CLIA Waiver

Feb 3, 2023

New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux

Feb 3, 2023

In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More

Dec 16, 2022

In Brief This Week: Meridian Bioscience, BioMérieux, Applied DNA Sciences, More

Oct 26, 2022

BioMérieux Q3 Revenues up 3 Percent

May 24, 2022

BioMérieux Gets Health Canada Approval for Updated BioFire Blood Culture ID Panel